Northeast Financial Consultants’s Thermo Fisher Scientific TMO Stock Holding History

Northeast Financial Consultants’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.67M	Buy	6,593 +96	+1%	+$40.1K	0.11%	92
2025 Q1	$3.23M	Hold	6,497	–	–	0.14%	84
2024 Q4	$3.38M	Sell	6,497 -71	-1%	-$39K	0.14%	81
2024 Q3	$4.06M	Buy	6,568 +9	+0.1%	+$5.33K	0.18%	72
2024 Q2	$3.63M	Buy	6,559 +37	+0.6%	+$21.2K	0.17%	74
2024 Q1	$3.79M	Sell	6,522 -50	-0.8%	-$28.1K	0.19%	77
2023 Q4	$3.49M	Buy	6,572 +210	+3%	+$102K	0.19%	75
2023 Q3	$3.22M	Hold	6,362	–	–	0.2%	74
2023 Q2	$3.32M	Hold	6,362	–	–	0.2%	74
2023 Q1	$3.67M	Sell	6,362 -181	-3%	-$102K	0.23%	63
2022 Q4	$3.6M	Hold	6,543	–	–	0.24%	65
2022 Q3	$3.32M	Hold	6,543	–	–	0.24%	65
2022 Q2	$3.56M	Sell	6,543 -49	-0.7%	-$27K	0.25%	67
2022 Q1	$3.89M	Buy	6,592 +49	+0.7%	+$28.1K	0.23%	68
2021 Q4	$4.37M	Sell	6,543 -22	-0.3%	-$13.7K	0.26%	57
2021 Q3	$3.75M	Sell	6,565 -23	-0.3%	-$12.6K	0.25%	60
2021 Q2	$3.32M	Buy	6,588 +12	+0.2%	+$5.66K	0.22%	68
2021 Q1	$3M	Buy	6,576 +32	+0.5%	+$15.3K	0.23%	65
2020 Q4	$3.05M	Sell	6,544 -255	-4%	-$120K	0.25%	63
2020 Q3	$3M	Sell	6,799 -7	-0.1%	-$2.89K	0.27%	57
2020 Q2	$2.47M	Sell	6,806 -17	-0.2%	-$5.7K	0.24%	64
2020 Q1	$1.94M	Buy	6,823 +4	+0.1%	+$1.26K	0.22%	71
2019 Q4	$2.21M	Sell	6,819 -5,315	-44%	-$1.61M	0.2%	78
2019 Q3	$3.53M	Buy	12,134 +65	+0.5%	+$18.6K	0.36%	59
2019 Q2	$3.54M	Buy	12,069 +70	+0.6%	+$19.3K	0.36%	53
2019 Q1	$3.28M	Sell	11,999 -774	-6%	-$193K	0.36%	48
2018 Q4	$2.86M	Buy	12,773 +11,773	+1,177%	+$2.76M	0.4%	46
2018 Q3	$244K	Hold	1,000	–	–	0.07%	130
2018 Q2	$207K	Hold	1,000	–	–	0.06%	135
2018 Q1	$206K	Sell	1,000 -500	-33%	-$105K	0.07%	136
2017 Q4	$284K	Sell	1,500 -4,000	-73%	-$766K	0.09%	117
2017 Q3	$1.04M	Hold	5,500	–	–	0.38%	48
2017 Q2	$960K	Hold	5,500	–	–	0.38%	51
2017 Q1	$844K	Hold	5,500	–	–	0.35%	53
2016 Q4	$776K	Hold	5,500	–	–	0.35%	56
2016 Q3	$875K	Hold	5,500	–	–	0.37%	49
2016 Q2	$813K	Hold	5,500	–	–	0.36%	48
2016 Q1	$779K	Hold	5,500	–	–	0.41%	48
2015 Q4	$780K	Sell	5,500 -1,000	-15%	-$133K	0.4%	50
2015 Q3	$795K	Hold	6,500	–	–	0.4%	47
2015 Q2	$843K	Hold	6,500	–	–	0.38%	52
2015 Q1	$873K	Hold	6,500	–	–	0.4%	52
2014 Q4	$814K	Hold	6,500	–	–	0.43%	49
2014 Q3	$791K	Hold	6,500	–	–	0.43%	50
2014 Q2	$767K	Hold	6,500	–	–	0.43%	51
2014 Q1	$781K	Hold	6,500	–	–	0.46%	50
2013 Q4	$724K	Buy	+6,500	New	+$646K	0.48%	40

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Northeast Financial Consultants's TMO Position: Q2 2025 in Review

Northeast Financial Consultants increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q2 2025, buying an estimated $40.1K and bringing the position to 6,593 shares worth $2.67M. The position accounts for 0.11% of the portfolio, ranked #92.

Northeast Financial Consultants first reported a position in TMO in Q4 2013 and has held it in 47 quarters since. The position peaked at $4.37M in Q4 2021. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Northeast Financial Consultants held 6,593 shares of Thermo Fisher Scientific worth $2.67M as of Q2 2025.
Northeast Financial Consultants bought 96 Thermo Fisher Scientific shares in Q2 2025, an estimated $40.1K.
Thermo Fisher Scientific made up 0.11% of Northeast Financial Consultants's portfolio in Q2 2025, its #92 holding.
Northeast Financial Consultants first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 47 quarters since.
Northeast Financial Consultants's Thermo Fisher Scientific position peaked at $4.37M in Q4 2021.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Northeast Financial Consultants's 13F filing for Q2 2025, filed 15 Aug 2025.